Description
A potent FoxO1 inhibitor (IC50 = 33 nM in HepG2 cells); causes a dose-dependent decrease in expression of G6Pase and PEPCK mRNAs and inhibits glucogenesis in Fao cells and a murine model of T2DM; inhibits 3T3-L1 preadipocyte differentiation and reduces lipid droplet growth in adipocytes
Formal name: 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Synonyms: FOXO1 Inhibitor
Molecular weight: 347.4
CAS: 836620-48-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors